作者: Zhang, Chaowei ; Wu, Yan ; Song, Xun ; Bian, Hedong ; Lei, Yubin ; Li, Xiaojian ; Ma, Jie ; He, Zhendan ; Guan, Yifu ; Zhao, Meirong ; Huang, Dongyu

JR20, a novel arylnaphthalene lignan derivative, exhibits potent antifungal activity against Cryptococcus neoformans (IC₅₀ = 2.82 μg/mL) through dual mechanisms targeting CYP51 and mitochondrial function. Mechanistic studies combining molecular docking, transcriptomics, and biochemical assays confirmed JR20's specific binding to CYP51, significantly reducing ergosterol biosynthesis and causing membrane disruption (evidenced by SEM/TEM showing cell wall collapse and plasmolysis). Flow cytometry revealed fungal necrosis induction, while mitochondrial dysfunction was demonstrated through membrane potential loss, ROS accumulation, and ATP synthesis impairment. In vivo studies using a murine deep infection model demonstrated JR20's therapeutic efficacy, showing both anti-infective and anti-inflammatory properties. As a lignan derivative, JR20 represents a promising antifungal candidate addressing drug resistance through its unique dual-action mechanism, highlighting the potential of natural product research for developing novel antifungals against resistant pathogens.

Frontiers in Microbiology

JR20, a novel natural product-derived compound, exhibits potent anti-biofilm activity against methicillin-resistant Staphylococcus aureus

Article

作者: Bian, Hedong ; Zhang, Chaowei ; Huang, Dongyu ; Guan, Yifu ; Jaiswal, Yogini ; Williams, Leonard ; Zhao, Meirong ; He, Zhendan ; Xie, Xinrong ; Song, Xun

Objective:

JR20, a novel sesamin-derived arylnaphthalene lignan, has demonstrated potent antifungal activity. This study further investigates its antibacterial potential against MRSA (methicillin-resistant Staphylococcus aureus ).

Methods:

The highlights of this research include the use of SYTO9 and PI fluorescence double staining, along with three-dimensional confocal microscopy to reveal the thickness and viability of biofilms under JR0′s influence. Additionally, scanning and transmission electron microscopy were employed to observe the morphological changes of MRSA under JR0′s impact. By combining the observed reduction in ATP content within MRSA, a preliminary mechanism was hypothesized. In vivo anti-infection experiments were further conducted to evaluate the compound's biological activity in liver and spleen tissues of mice.

Results:

JR20 exhibited potent anti-MRSA activity (IC 50 = 20.88 μg/mL). Mechanistic investigations revealed multi-level effects: confocal microscopy demonstrated altered biofilm thickness and viability; SEM/TEM confirmed distinct morphological changes in bacterial cells; And ATP content reduction indicated metabolic disruption. In vivo experiments validated these antibacterial effects and further revealed anti-inflammatory properties, underscoring JR0′s therapeutic potential against MRSA infections.

Conclusion:

This study confirms JR0′s potent anti-MRSA activity, clarifies its effects on biofilms and MRSA morphology, and proposes a preliminary mechanism by reduced ATP. JR20 demonstrates significant potential for combating drug-resistant bacteria and advancing antibiofilm drug discovery.

100 项与 JR20(Shenzhen University) 相关的药物交易

登录后查看更多信息